(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DOUBLEMIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

DOUBLEMIN

ST13

US500000079130045

Class

5

Filing

79130045

Registration

4523886

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

05/09/2023

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

02/27/2013

Registration date

05/06/2014

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/26/2021

Last transaction

02/26/2021

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Aichi-ken 460-8625, JP

Examiner

FAIRBANKS, RONALD L

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

KOWA COMPANY, LTD.
KOWA COMPANY, LTD.

Representatives

Thomas J. Moore BACON & THOMAS, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of conditions and diseases of the central nervous systemthe peripheral nervous systemthe sensory organsthe circulatory systemthe respiratory systemthe digestive system; Pharmaceutical preparations comprising hormones; Pharmaceutical preparations for the treatment of urogenital or anal conditions; Pharmaceutical preparations for the treatment of dermatological conditions; Pharmaceutical preparations comprising vitamins and amino acids; Pharmaceutical preparations for the treatment of blood conditions and metabolic conditions; Pharmaceutical preparations for treating tumors and lesions; Pharmaceutical preparations comprising antibiotics; Pharmaceutical preparations for treating medical conditions caused by parasites; Pharmaceutical preparations comprising labeled isotopes; Pharmaceutical preparations comprising narcotics; Preparations for destroying verminfungicidesherbicides; reagent paper for medical purposes; oiled paper for medical purposes; wrapping wafers for dosing of medicine; gauze for dressings; empty capsules for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid dressings; breast-nursing pads; dietary supplements for humans

Publications

History of USPTO decisions and trademark events.

36 publications found

FINP

FINAL DECISION TRANSACTION PROCESSED BY IB

05/09/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/10/2023

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

01/17/2023

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

01/12/2023

XXCR

GENERIC MADRID TRANSACTION CREATED

01/12/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/05/2022

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

10/26/2021

C71T

CANCELLED SECTION 71

02/26/2021

GPNX

NOTIFICATION PROCESSED BY IB

06/19/2020

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/06/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/10/2014

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/23/2014

FIMP

FINAL DISPOSITION PROCESSED

09/23/2014

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/06/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

05/06/2014

GPNX

NOTIFICATION PROCESSED BY IB

02/18/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/18/2014

PUBO

PUBLISHED FOR OPPOSITION

02/18/2014

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/29/2014

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/29/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/29/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/14/2014

ALIE

ASSIGNED TO LIE

01/13/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/15/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/13/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/12/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/12/2013

RFNP

REFUSAL PROCESSED BY IB

07/07/2013

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/18/2013

RFRR

REFUSAL PROCESSED BY MPU

06/18/2013

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/18/2013

CNRT

NON-FINAL ACTION WRITTEN

06/17/2013

DOCK

ASSIGNED TO EXAMINER

06/11/2013

MAFR

APPLICATION FILING RECEIPT MAILED

06/04/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/31/2013

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/30/2013

Continuous trademark protection

Get notified about every new filing that threatens DOUBLEMIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.